drugset / Trial / NCT00701233

Botulinum Toxin for Carpal Tunnel Syndrome

NCT00701233

Phase 2 Withdrawn University of Minnesota
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To compare local steroid injections to local Botulinum toxin A injection in a double-blinded study.

Timeline

Start
2012-06
Primary completion
2018-10
Completion
2018-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin Protein / enzyme biologic 45 unknown Other
Subject Triamcinolone Other / unclassified 40 mg Other
Background Lidocaine Other / unclassified 1 ml Other